Comparing Cancer Risk Management Between Females with Truncating CHEK2 1100delC versus Missense CHEK2 I157T Variants
07:30am - 03:35pm EDT - April 5, 2024


Comparing Cancer Risk Management Between Females with Truncating CHEK2 1100delC versus Missense CHEK2 I157T Variants icon

Abstract:  JNCCN23-0521 https://jnccn.org/view/journal...


Author(s):
  • Diego Garmendia, BA, Undergraduate Student at Vanderbilt University, Vanderbilt-Ingram Cancer Center

Tags: Member Institution Best Practices in Implementation and Use of Clinical Practice Gu

Display Label Action
035 - General Poster Session Download Handout
Comparing Cancer Risk Management Between Females with Truncating CHEK2 1100delC versus Missense CHEK2 I157T Variants_NCCN Poster.pdf Download Handout